beta-Carbolinium cations, endogenous MPPplus analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease
beta-Carbolinium cations, endogenous MPPplus analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease
复制标题
帕金森病患者腰部脑脊液中的 β-Carbolinium 阳离子(内源性 MPPplus 类似物)
DOI:
10.1212/wnl.45.12.2240
复制
发表时间:
1995
期刊:
影响因子:
9.9
通讯作者:
K. Kimura
中科院分区:
文献类型:
--
作者:
K. Matsubara;Shotai Kobayashi;Y. Kobayashi;K. Yamashita;H. Koide;M. Hatta;K. Iwamoto;O. Tanaka;K. Kimura
We measured beta-carbolinium cations (BCplus s), endogenous analogs of the N-methyl-4-phenylpyridinium ion (MPPplus), in the lumbar CSF of 22 patients with idiopathic Parkinson's disease (PD) and 11 age-matched controls without any symptoms of parkinsonism. Among the BCplus s, 2,9-dimethylnorharmanium cation (2,9-Me2 NHplus), the most potent neurotoxicant that mirrors MPPplus in mitochondria toxicity, was present in 12 patients with PD but not in controls. Although the 2-monomethylated beta-carbolinium cations (2-MeBCplus s), which were present in almost all subjects, registered a slightly higher level in PD patients than in controls, the difference was not significant. The total BCplus content, sum of 2-MeBCplus and 2,9-Me2 NHplus levels, was significantly higher in PD patients than in controls. The 2-MeBCplus contents significantly increased with the progression of the PD, but 2,9-ME2 NHplus decreased as the disease exacerbated, although levels varied within a wide range. The present results strongly support the hypothesis that ``bioactivated'' BCplus s, especially 2,9-Me2 NHplus s, may be the endogenous causative factors underlying PD. NEUROLOGY 1995;45: 2240-2245
DOI:
10.1016/0006-291x(85)91071-x
发表时间:
1985-01-01
影响因子:
3.1
作者:
CHIBA, K;TREVOR, AJ;CASTAGNOLI, N
通讯作者:
CASTAGNOLI, N
影响因子:
6.1
作者:
ARORA, PK;RIACHI, NJ;SAYRE, LM
通讯作者:
SAYRE, LM
DOI:
10.1073/pnas.82.7.2173
发表时间:
1985-01-01
影响因子:
11.1
作者:
JAVITCH, JA;DAMATO, RJ;SNYDER, SH
通讯作者:
SNYDER, SH